Although some dihydropyridine compounds have been found to be teratogenic in animals, data in the rat and rabbit for amlodipine provide no evidence for a teratogenic effect. There is, however, no clinical experience with the preparation in pregnancy or lactation. Accordingly, ALMOBEST should not be administered during pregnancy, or lactation, or to women of childbearing potential unless effective contraception is used.